Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals

F Li, Y Yang, J Liao, N Liu - Chinese Chemical Letters, 2022 - Elsevier
Abstract Astatine-211 (211 At, t 1/2= 7.21 h) emitting two α particles with energies of 5.87
and 7.45 MeV, can lead to a high linear energy transfer (LET= 98.84 keV/µm) and short …

Marshalling the potential of Auger electron radiopharmaceutical therapy

J Bolcaen, MA Gizawy, SYA Terry, A Paulo… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Auger electron (AE) radiopharmaceutical therapy (RPT) may have the same therapeutic
efficacy as α-particles for oncologic small disease, with lower risks of normal-tissue toxicity …

Efficacy of HER2-targeted intraperitoneal 225Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis

SK Chung, DB Vargas, CS Chandler… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Epithelial ovarian cancer (EOC) is often asymptomatic and presents clinically in an
advanced stage as widespread peritoneal microscopic disease that is generally considered …

[HTML][HTML] In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy

HS Chan, E De Blois, A Morgenstern, F Bruchertseifer… - PLoS …, 2017 - journals.plos.org
Background Absorbed doses for α-emitters are different from those for β-emitters, as the high
linear energy transfer (LET) nature of α-particles results in a very dense energy deposition …

Advancements in the use of Auger electrons in science and medicine during the period 2015–2019

RW Howell - International journal of radiation biology, 2023 - Taylor & Francis
Auger electrons can be highly radiotoxic when they are used to irradiate specific molecular
sites. This has spurred basic science investigations of their radiobiological effects and …

[HTML][HTML] Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate

HS Chan, MW Konijnenberg, E de Blois, S Koelewijn… - EJNMMI research, 2016 - Springer
Background Targeted alpha therapy has been postulated to have great potential for the
treatment of small clusters of tumour cells as well as small metastases. 213 Bismuth, an α …

[HTML][HTML] Radioimmunotherapy of pancreatic ductal adenocarcinoma: a review of the current status of literature

A Hull, Y Li, D Bartholomeusz, W Hsieh, B Allen… - Cancers, 2020 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) has long been associated with low survival
rates. A lack of accurate diagnostic tests and limited treatment options contribute to the poor …

Radioimmunotherapy for prostate cancer—current status and future possibilities

S Evans-Axelsson, OV Timmermand, A Bjartell… - Seminars in nuclear …, 2016 - Elsevier
Prostate cancer (PCa) is one of the most common cancers in men and is the second leading
cause of cancer-related deaths in the USA. In the United States, it is the second most …

[HTML][HTML] Radioimmunotherapy for CD133 (+) colonic cancer stem cells inhibits tumor development in nude mice

D Weng, X Jin, S Qin, X Lan, C Chen, X Sun, X She… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Accumulating evidence indicates that cancer stem cells (CSCs) are the cause of tumor
drug/radio-resistance or distant metastasis; therefore, it is essential to eliminate CSCs to …

Radiotheranostic targeting cancer stem cells in human colorectal cancer xenografts

X She, S Qin, B Jing, X Jin, X Sun, X Lan… - Molecular Imaging and …, 2020 - Springer
Purpose The aim of this study was to perform radiotheranostics with radioiodinated
monoclonal antibodies (mAbs) for targeting cancer stem cells (CSCs) in human colorectal …